Cigna Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 12.23%

Cigna Corporation Return on Equity (ROE) is 12.23% for the Trailing 12 Months (TTM) ending March 31, 2025, a 50.76% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Cigna Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 8.11%, a -45.84% change year over year.
  • Cigna Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 14.97%, a 31.23% change year over year.
  • Cigna Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 11.41%, a -34.46% change year over year.
  • Cigna Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 17.41%, a 58.38% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share